Search Ontology:
ChEBI
alpha-D-Glcp-(1->2)-[beta-D-Glcp-(beta-1->3)]-D-Galp
- Term ID
- CHEBI:146945
- Synonyms
-
- (2S,3R,4S,5S,6R)-2-[(3R,4S,5S,6R)-2,5-Dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- alpha-D-gluco-hexopyranosyl-(1->2)-[beta-D-gluco-hexopyranosyl-(1->3)]-D-galacto-hexopyranose
- alpha-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)]-D-galactopyranose
- Glc(a1-2)[Glc(b1-3)]Gal
- WURCS=2.0/3,3,2/[a2112h-1x_1-5][a2122h-1a_1-5][a2122h-1b_1-5]/1-2-3/a2-b1_a3-c1
- Definition
- A trisaccharide that is D-galactopyranose in which the hydroxy group at position 2 has been converted to the corresponding alpha-D-glucopyranoside, while that at position 1 has been converted into the corresponding beta-D-glucopyranoside.
- References
-
- GlyGen:G06172YF
- GlyTouCan:G06172YF
- KEGG:G08095
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-D-Glcp-(1->2)-[beta-D-Glcp-(beta-1->3)]-D-Galp
Phenotype where environments contain alpha-D-Glcp-(1->2)-[beta-D-Glcp-(beta-1->3)]-D-Galp
Phenotype modified by environments containing alpha-D-Glcp-(1->2)-[beta-D-Glcp-(beta-1->3)]-D-Galp
Human Disease Model